Pfizer and the FDA view Paxlovid as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections.
You are here: Home / FDA grants full approval to Pfizer Covid treatment Paxlovid for high-risk adults
Market News and Views
Pfizer and the FDA view Paxlovid as an important complementary tool to vaccination that can help high-risk Americans manage their Covid infections.